Myriad Genetics MYGN Cash Flow Statement (2009-2026)

NASDAQ MYGN
$4.23 -0.01 (-0.24%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Myriad Genetics Quarterly Cash Flow Statement

Periods 68 quarters
Latest Jun 2026

Myriad Genetics reported cash from operations of -$8.30M and free cash flow of -$10.40M for the quarter ended Jun 2026, up 39.0% year over year. This cash flow statement covers 68 quarters of results from Sep 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
24.60M-7.60M-20.50M-14.10M-35.10M-42.30M-54.70M-116.10M-61.30M-31.20M-26.00M-36.70M-22.10M-42.50M-0.10M-330.50M-27.40M-7.90M-34.10M-43.20M
Depreciation and DepletionDep. & Depletion
2.60M3.20M2.80M2.80M2.90M3.10M8.70M2.70M3.40M4.30M4.90M4.60M4.80M5.00M5.10M4.90M4.80M4.70M4.70M4.80M
Share-based CompensationStock Comp.
10.00M8.40M10.10M10.40M9.40M8.20M7.50M11.20M11.60M10.40M12.00M14.50M12.40M10.90M9.50M10.70M12.20M2.80M6.50M7.20M
Deferred Taxes
-16.30M-4.30M-5.90M-4.70M-11.40M-8.80M0.10M-0.80M-1.00M-2.30M0.60M-2.20M-1.40M0.20M0.10M
Gains from Sales and DivestituresGains Divest
129.60M
Asset Writedowns and ImpairmentWritedown
10.70M6.20M1.20M11.60M0.80M43.00M316.70M2.70M5.40M
Cash from OperationsCash from Ops.
-39.30M-9.50M-46.50M-49.70M-2.80M-7.30M-33.20M-0.90M-22.10M-54.70M-18.60M2.60M0.70M6.60M-16.30M-13.60M21.10M10.60M-15.70M-8.30M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
14.20M13.30M13.00M12.90M13.10M13.70M19.40M13.30M14.10M15.10M15.70M15.10M15.60M14.80M14.40M14.10M12.60M12.60M12.50M12.50M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.50M-3.00M10.50M8.40M-6.10M-2.50M17.50M-7.40M3.60M-1.20M3.90M0.60M8.20M-4.00M-0.80M16.20M-19.00M-2.60M8.70M-14.40M
Change in InventoryChange Inventory
0.80M-3.20M0.20M-0.10M4.30M-1.50M1.70M0.60M2.70M-3.20M1.80M3.10M1.30M0.90M0.30M2.90M-0.90M-2.70M
Change in Account PayablesChange Payables
-12.90M14.00M-3.20M-5.00M7.10M-2.40M7.60M3.10M-8.50M-5.90M6.10M3.30M-3.60M-1.10M3.60M-0.80M-4.20M5.40M-2.50M
Change in Accured ExpensesChange Accured Exp.
62.50M-14.20M-35.30M-47.60M-0.50M-2.80M-6.50M71.90M21.20M-59.40M-14.60M-5.50M6.60M-27.50M-12.40M-16.80M8.40M-6.70M-7.40M1.00M
Change in TaxesChange Taxes
-18.20M18.10M0.40M0.50M-1.40M-0.20M0.10M-0.30M-0.50M1.40M-1.30M-0.60M-2.10M-0.50M-1.80M-10.00M-0.20M
Other Working Capital ChangesOther WC Changes
-11.20M-6.20M-4.50M-0.40M6.60M2.30M2.80M-2.10M1.40M2.70M-1.60M0.10M0.30M-0.50M1.00M1.10M1.80M1.20M0.70M
Investing Activities
Capital ExpendituresCapex
3.00M3.40M6.30M6.70M17.70M14.60M23.50M18.80M10.90M10.00M6.70M5.20M3.50M3.60M5.30M2.80M2.80M4.70M5.40M2.10M
Sales of Property, Plant and EquipmentPP&E (Sale)
346.60M
Change in IntangiblesChange Intangibless
6.60M3.50M1.90M3.70M2.80M2.30M3.00M4.10M3.40M1.30M1.10M1.10M
Acquisitions
Divestments
379.10M
Cash from Investing ActivitiesCash from Investing
291.00M-25.90M-41.30M-12.00M11.40M-35.60M34.60M11.80M-2.50M-12.00M-7.10M-6.40M7.50M-5.90M-8.30M-6.90M-6.20M-6.00M-6.50M-3.20M
Financing Activities
Other financing activitiesOther financing
7.40M2.90M5.10M0.20M3.80M1.50M4.90M0.20M2.20M1.50M8.70M0.50M3.00M1.20M5.80M2.60M-1.10M2.90M0.40M
Cash from Financing ActivitiesCash from Financing
-74.50M-1.10M-4.80M2.50M-3.60M-2.10M-4.90M38.40M-2.50M121.90M-8.80M2.40M-3.10M2.10M13.60M2.60M56.20M-8.20M-3.00M2.20M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
39.90M1.80M0.30M2.70M0.90M2.40M117.60M2.90M0.60M
Additional items
Exchange Rate EffectFX Effect
-0.40M0.10M-0.60M-0.20M-0.50M0.70M0.20M0.30M-0.60M0.70M-0.80M-0.70M1.20M-0.70M0.10M0.60M0.10M-0.10M0.10M
Change in Cash
176.80M-36.40M-93.20M-59.40M4.50M-44.30M-3.30M49.60M-27.70M55.90M-35.30M-4.40M8.60M2.10M-10.90M-17.30M71.10M-3.50M-25.30M-9.20M
Free Cash FlowFCF
-42.30M-12.90M-52.80M-56.40M-20.50M-21.90M-56.70M-19.70M-33.00M-64.70M-25.30M-2.60M-2.80M3.00M-21.60M-16.40M18.30M5.90M-21.10M-10.40M
Net Cash FlowNCF
177.20M-36.50M-92.60M-59.20M5.00M-45.00M-3.50M49.30M-27.10M55.20M-34.50M-1.40M5.10M2.80M-11.00M-17.90M71.10M-3.60M-25.20M-9.30M

Myriad Genetics Cash Flow Statement API

Pull Myriad Genetics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MYGN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY